NCT04263428 is a NA clinical trial of Irregular sleep in Sleep Variability, sponsored by The University of Hong Kong.

Who is sponsoring NCT04263428?

NCT04263428 is sponsored by The University of Hong Kong.

What drugs are being tested in NCT04263428?

Interventions in NCT04263428: Irregular sleep.

What condition does NCT04263428 study?

NCT04263428 studies Sleep Variability.

Is NCT04263428 still recruiting?

NCT04263428 is currently completed. Last updated 11 May 2021.

Last reviewed 2021-05-11 · How we verify

NCT04263428

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effects of Sleep Variability in Youth

Completed NA Last updated 11 May 2021

What this trial tests

NA trial testing Irregular sleep in Sleep Variability in 41 participants. Completed in 1 January 2021.

Timeline

1 June 2019

Primary endpoint
1 January 2021

1 January 2021

Quick facts

Lead sponsor	The University of Hong Kong
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	41
Start date	1 June 2019
Primary completion	1 January 2021
Estimated completion	1 January 2021
Sites	1 location across Hong Kong

Drugs / interventions tested

Irregular sleep

Conditions studied

Sleep Variability — all drugs for Sleep Variability →

Sponsor

The University of Hong Kong

Who can join

Adults 18 to 25, any sex, with Sleep Variability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Daily sleep variability is prevalent in the young populations, yet its effects remain less clear. The experimental study aims to examine the impacts of intraindividual daily sleep variability on sleep characteristics, cardiometabolic regulations and daytime functioning in college students.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other The University of Hong Kong trials

Trials by the same sponsor.

NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04263428 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
Last refreshed: 11 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04263428.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing